InMed Pharmaceuticals Inc (NASDAQ:INM)
| 1.92 Delayed Data As of Jan 26 |  -0.01 / -0.52%Today’s Change | 1.23 Today|||52-Week Range 35.50 | -4.95% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Depreciation And Amortization | 80.2K | 65.8K | 73.7K | 92.8K | ||
| Operating Expenses | Gross Income | -80.2K | -65.8K | -73.7K | -92.8K | |
| General Expenses | 3.6M | 1.7M | 3.3M | 6.7M | ||
| Research And Development | 804.5K | 285.7K | 562.5K | 1.5M | ||
| Total Operating Expenses | 3.7M | 1.8M | 3.4M | 6.8M | ||
| Non-Operating Expenses | Operating Income | -3.7M | -1.8M | -3.4M | -6.8M | |
| Other Expenses | -1.9K | -20.00 | -240.00 | 230.00 | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -3.7M | -1.8M | -3.4M | -6.7M | |
| Net Income | -3.7M | -1.8M | -3.4M | -6.7M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 46.1M | 60.2M | 96.8M | 142.5M | |
| Shares To Calculate EPS Diluted | 46.1M | 60.2M | 96.8M | 142.5M | ||
| Earnings Per Share | EPS | -$0.08 | -$0.03 | -$0.04 | -$0.05 | |
| EPS Diluted | -$0.08 | -$0.03 | -$0.04 | -$0.05 | ||
